Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Dyne Therapeutics to Host Investor Conference Call and Webcast to Review Topline Results from Registrational Expansion Cohort (REC) of DELIVER Clinical Trial of Z-Rostudirsen (DYNE-251) in Duchenne Muscular Dystrophy; Tomorrow, December 8 at 8:00 a.m. ET
From Dyne Therapeutics, Inc.
Via GlobeNewswire
Tickers DYN
News headline image
Nayax Considering an Offering of Notes and Warrants in Israel
From Nayax Ltd.
Via GlobeNewswire
Tickers NYAX
News headline image
Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease
From Prime Medicine, Inc.
Via GlobeNewswire
Tickers PRME
News headline image
ALX Oncology Announces Positive Results from Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with Indolent B-cell Non-Hodgkin Lymphoma, at ASH Annual Meeting
From ALX Oncology
Via GlobeNewswire
Tickers ALXO
News headline image
Molecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial of MP0533 in AML at ASH Annual Meeting
From Molecular Partners
Via GlobeNewswire
Tickers MOLN
News headline image
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Stride, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LRN
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers LRN
News headline image
Balancer Announcement: If You Have Suffered Losses in Balancer Cryptocurrency, You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
CRMT Investor News: If You Have Suffered Losses in America’s Car-Mart, Inc. (NASDAQ: CRMT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers CRMT
News headline image
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
From Fulcrum Therapeutics, Inc.
Via GlobeNewswire
Tickers FULC
News headline image
TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
News headline image
DXCM DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers DXCM
News headline image
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers ALVO
News headline image
Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness
From Remedy's Nutrition
Via GlobeNewswire
News headline image
Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
From Legend Biotech USA Inc.
Via GlobeNewswire
Tickers LEGN
News headline image
THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality
From USA News Group
Via GlobeNewswire
Tickers AVAI CSE:GOH GHVNF ONCY TSX-V:VPT VPTDF
News headline image
AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers AGL
News headline image
Anthony Constantino’s ‘Thank You President Trump’ Album Release To Light Up Fontainebleau LIV Tonight; Hit song “Fight” has over 4 million views in 5 days
From Sticker Mule
Via GlobeNewswire
News headline image
Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs
From Prelude Therapeutics, Incorporated
Via GlobeNewswire
Tickers PRLD
News headline image
BLUE OWL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Blue Owl Capital, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
CEPTON URGENT ALERT: Bragar Eagel & Squire, P.C. Reminds Cepton Stockholders of Upcoming December 8th Lead Plaintiff Deadline
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MAREX URGENT DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Marex Stockholders to Contact the Firm Before December 8th Deadline
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers MRX
News headline image
ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds aTyr Investors to Contact the Firm Before December 8th Regarding Their Rights
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers ATYR
News headline image
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages StubHub Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STUB
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers STUB
News headline image
Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human
From Io Therapeutics, Inc.
Via GlobeNewswire
News headline image
Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition
From Arvinas Inc.
Via GlobeNewswire
Tickers ARVN
News headline image
Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting
From Beam Therapeutics
Via GlobeNewswire
Tickers BEAM
News headline image
Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations
From Aptose Biosciences, Inc.
Via GlobeNewswire
Tickers APTOF TSX:APS
News headline image
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
From Disc Medicine Inc
Via GlobeNewswire
Tickers IRON
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.